JPH07103112B2 - 5‐フルオロウラシル誘導体 - Google Patents

5‐フルオロウラシル誘導体

Info

Publication number
JPH07103112B2
JPH07103112B2 JP62-502695A JP50269587A JPH07103112B2 JP H07103112 B2 JPH07103112 B2 JP H07103112B2 JP 50269587 A JP50269587 A JP 50269587A JP H07103112 B2 JPH07103112 B2 JP H07103112B2
Authority
JP
Japan
Prior art keywords
group
pyridyl
groups
pyridin
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP62-502695A
Other languages
English (en)
Japanese (ja)
Other versions
JPH07103112B1 (enExample
JPWO1987006582A1 (ja
Inventor
節郎 藤井
満 廣橋
栄仁 山本
裕 小島
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Priority to JP62-502695A priority Critical patent/JPH07103112B2/ja
Publication of JPWO1987006582A1 publication Critical patent/JPWO1987006582A1/ja
Publication of JPH07103112B2 publication Critical patent/JPH07103112B2/ja
Publication of JPH07103112B1 publication Critical patent/JPH07103112B1/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
JP62-502695A 1986-04-30 1987-04-30 5‐フルオロウラシル誘導体 Expired - Lifetime JPH07103112B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP62-502695A JPH07103112B2 (ja) 1986-04-30 1987-04-30 5‐フルオロウラシル誘導体

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP61-101285 1986-04-30
JP10128586 1986-04-30
JP62-45754 1987-02-27
JP4575487 1987-02-27
PCT/JP1987/000275 WO1987006582A1 (fr) 1986-04-30 1987-04-30 Derives de 5-fluorouracyle
JP62-502695A JPH07103112B2 (ja) 1986-04-30 1987-04-30 5‐フルオロウラシル誘導体

Publications (3)

Publication Number Publication Date
JPWO1987006582A1 JPWO1987006582A1 (ja) 1988-03-03
JPH07103112B2 true JPH07103112B2 (ja) 1995-11-08
JPH07103112B1 JPH07103112B1 (enExample) 1995-11-08

Family

ID=26385819

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62-502695A Expired - Lifetime JPH07103112B2 (ja) 1986-04-30 1987-04-30 5‐フルオロウラシル誘導体

Country Status (9)

Country Link
US (1) US5047521A (enExample)
EP (1) EP0247381B1 (enExample)
JP (1) JPH07103112B2 (enExample)
KR (1) KR950002161B1 (enExample)
DE (1) DE3786834T2 (enExample)
DK (1) DK166088C (enExample)
ES (1) ES2058073T3 (enExample)
GB (1) GB2200352B (enExample)
WO (1) WO1987006582A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4864021A (en) * 1984-10-30 1989-09-05 Otsuka Pharmaceutical Co., Ltd. 5-fluorouracil derivatives
AU610913B2 (en) * 1987-07-31 1991-05-30 Taiho Pharmaceutical Co., Ltd. 2'-deoxy-5-fluorouridine derivatives
US4992534A (en) * 1987-08-12 1991-02-12 Otsuka Pharmaceutical Co., Ltd. 3'-O-,5'-O-derivatives of 2'-deoxy-5-fluorouridine
US7442475B2 (en) * 2003-02-22 2008-10-28 Merck Patent Gmbh Cyanopyridone derivatives as liquid crystals
US20080050425A1 (en) * 2003-05-20 2008-02-28 Jonathan Lewis Combination Chemotherapy Comprising 5-Fluorouracil or a Derivative Thereof and a Liposomal Platinum Complex
JP2007077109A (ja) * 2005-09-16 2007-03-29 Tokyo Institute Of Technology ヌクレオシド誘導体及びその製造方法
US7561776B2 (en) * 2005-11-29 2009-07-14 Petrospec Engineering Ltd. Method of preventing hydrogen darkening of optic fibre
AU2013203591B2 (en) * 2009-05-01 2017-01-19 University Court Of The University Of Dundee Treatment or prophylaxis of proliferative conditions
GB0907551D0 (en) * 2009-05-01 2009-06-10 Univ Dundee Treatment or prophylaxis of proliferative conditions
CN102574837B (zh) * 2009-10-27 2013-11-27 德尔塔菲制药股份有限公司 新的5-氟尿嘧啶衍生物
CA3091027A1 (en) 2018-02-02 2019-08-08 Maverix Oncology, Inc. Small molecule drug conjugates of gemcitabine monophosphate

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4124765A (en) * 1975-05-13 1978-11-07 Ono Pharmaceutical Co., Ltd. 5-Fluorouracil derivatives
JPS6011704B2 (ja) * 1976-07-30 1985-03-27 大鵬薬品工業株式会社 5−フルオルウラシル誘導体の製造法
JPS5379879A (en) * 1976-12-23 1978-07-14 Mitsui Toatsu Chem Inc 1,3-substituted-5-fluorouracils and process for their preparation
DE2658672A1 (de) * 1976-12-23 1978-06-29 Robugen Gmbh Neue nucleosid-verbindungen und verfahren zu ihrer herstellung
JPS5924999B2 (ja) * 1978-06-10 1984-06-13 富山化学工業株式会社 新規な5−フルオロ−2′−デオキシ−β−ウリジン誘導体の製造法
JPS5535057A (en) * 1978-09-05 1980-03-11 Funai Corp 2'-deoxy-5-fluorouridine derivative, its preparation, and antitumor agent comprising it
US4340728A (en) * 1979-11-28 1982-07-20 Fuji Kagaku Kogyo Kabushiki Kaisha Nucleoside derivatives and process for preparing same
GB2072164B (en) * 1980-02-15 1983-12-21 Funai Pharmaceutical Ind Ltd 2'-deoxy-3',5'-di-o-alkylcarbonyl-5-fluorouridine derivatives a process for the preparation of the derivatives and antitumor agents containing the derivatives
JPS5929699A (ja) * 1982-08-11 1984-02-16 Funai Corp 2′−デオキシ−5−フルオロウリジンのエ−テル誘導体およびその製造方法並びにこれを含有する抗腫瘍剤
JPS58185522A (ja) * 1983-02-28 1983-10-29 Toyama Chem Co Ltd 新規な5−フルオロ−2′−デオキシ−β−ウリジン誘導体
JPS6061593A (ja) * 1983-09-14 1985-04-09 Taiho Yakuhin Kogyo Kk 2’−デオキシ−5−トリフルオロメチルウリジン誘導体及びそれを含む抗腫瘍剤
AU548712B2 (en) * 1983-05-23 1986-01-02 Taiho Pharmaceutical Co., Ltd. 2:-deoxy-5-substituted uridine derivatives
WO1985000608A1 (fr) * 1983-07-20 1985-02-14 Teijin Limited Agent antineoplastique
US4515618A (en) * 1983-12-07 1985-05-07 Chevron Research Company 5-Deoxy-3-O-thienylmethyl or furylmethyl-1,2-O-alkylidene-alpha-D-xylofuranose herbicide derivatives
DE3585869D1 (de) * 1984-10-30 1992-05-21 Otsuka Pharma Co Ltd Zusammensetzung zur steigerung der antikrebsaktivitaet einer antikrebsverbindung.
AU610913B2 (en) * 1987-07-31 1991-05-30 Taiho Pharmaceutical Co., Ltd. 2'-deoxy-5-fluorouridine derivatives
US4992534A (en) * 1987-08-12 1991-02-12 Otsuka Pharmaceutical Co., Ltd. 3'-O-,5'-O-derivatives of 2'-deoxy-5-fluorouridine
JPH02187484A (ja) * 1989-01-13 1990-07-23 Okitsumo Kk 紙用瞬間接着剤

Also Published As

Publication number Publication date
DK691287A (da) 1988-02-19
DK166088C (da) 1993-08-23
EP0247381A2 (en) 1987-12-02
KR880701232A (ko) 1988-07-26
EP0247381B1 (en) 1993-08-04
US5047521A (en) 1991-09-10
DK166088B (da) 1993-03-08
EP0247381A3 (en) 1988-11-23
WO1987006582A1 (fr) 1987-11-05
GB2200352A (en) 1988-08-03
JPH07103112B1 (enExample) 1995-11-08
ES2058073T3 (es) 1994-11-01
DK691287D0 (da) 1987-12-29
GB8730031D0 (en) 1988-02-03
DE3786834D1 (de) 1993-09-09
GB2200352B (en) 1990-07-25
KR950002161B1 (ko) 1995-03-14
DE3786834T2 (de) 1994-03-03

Similar Documents

Publication Publication Date Title
EP2296653B1 (en) Compounds and methods for treating inflammatory and fibrotic disorders
KR950002161B1 (ko) 5-플루오로우라실 유도체의 제조방법
CA2463284A1 (en) Pyrimidine compounds and pharmaceutical compositions containing the compounds
US20110124680A1 (en) Novel anthranilamide pyridinureas as vascular endothelial growth factor (vegf) receptor kinase inhibitors
JPWO1987006582A1 (ja) 5‐フルオロウラシル誘導体
EP1628957B1 (en) Sulfopyrroles
JP2010522214A (ja) アデノシンレセプターアンタゴニストとしての置換ピリミジン
EP0180188B1 (en) A composition for increasing the anti-cancer activity of an anti-cancer compound
WO2006105222A2 (en) Carboxamide inhibitors of tgfb
US20150166505A1 (en) Pyridinyl-substituted pyrazolyl carboxamides
KR920006824B1 (ko) 5-플루오로우라실 유도체의 제조방법
KR950003927B1 (ko) 5-플루오로우라실 유도체
Katz et al. Synthesis of pyridazine analogs of the naturally occurring nucleosides cytidine, uridine, deoxycytidine and deoxyuridine
JPS63201127A (ja) 5−フルオロウラシル誘導体を含有する制癌剤
JPS63301880A (ja) 5−フルオロウラシル誘導体
JPH0580451B2 (enExample)
JPH0153878B2 (enExample)
HK1155374B (en) Compounds and methods for treating inflammatory and fibrotic disorders